|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.32 EGP | +2.41% |
|
-0.15% | -9.09% |
GlaxoSmithKline S.A.E reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EGP 2,240.22 million compared to EGP 1,823.23 million a year ago. Net income was EGP 74.1 million compared to EGP 718.18 million a year ago.
Basic earnings per share was EGP 0.89 compared to EGP 8.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.09% | 56.35M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
GLAXOSMITHKLINE S.A.E 
